Home > Analytics > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 544222     NSE : AKUMS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Mar 13,2025
Price(EOD): ₹ 510.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 8,036.06 Cr
Value of ₹ 1 Lac invested in AKUMS DRUGS & PHARMACEUTICALS
on Aug 06,2024 (price: ₹ 796.35)

₹ 1 L

₹ 0.64 L

1W : 1.3% 1M : -5.7% 1Y : NA
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
AKUMS DRUGS & PHARMACEUTICALS 1.3% -5.7% NA
SUN PHARMACEUTICAL INDUSTRIES 4.6% -0.9% 5.3%
DIVIS LABORATORIES 0.5% -5.5% 57.2%
CIPLA 0.2% 0.6% -3.3%
TORRENT PHARMACEUTICALS -0.4% -1.5% 14.8%
DR REDDYS LABORATORIES -2.2% -8.6% -13.4%
MANKIND PHARMA -4.9% -10.2% 0.3%
ZYDUS LIFESCIENCES -2.1% -6.3% -10.6%
LUPIN -3% -4.7% 17.3%

FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Dec2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AKUMS DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Mar 13,2025 ]

Ratio Consolidated
P/E
P/B
P/S
20.65
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 389.17 Cr
[Latest Qtr - Dec2024 - Consolidated Results ]

11.33
P/B Calculated based on Book Value of Rs 709.50 Cr
[Latest Year - Mar2024 - Consolidated Results ]

1.94
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,145.45 Cr
[Latest Qtr - Dec2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF AKUMS DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
27349%
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS



AKUMS DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AKUMS DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
1.57
0.47
0.66
0.9
0.69
0.75
0.58
0.67
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Dec2024

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-2.19%
0.15%
-0.58%
-0.51%
-14.46%
-20.07%
4.51%
102.86%
QtrlyTrend
-2
Latest Qtr: Dec2024
Quarterly Result Analysis →


AKUMS DRUGS & PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE IPO -3.3% -10% -3.2%
NSE Indices1W1M1Y
NIFTY 500 -1.3% -5.6% -1.3%
NIFTY TOTAL MARKET -1.4% -5.8% -1.2%
NIFTY500 MULTICAP 50:25:25 -1.7% -6.6% -1.5%
NIFTY MIDSMALLCAP 400 -2.5% -8.6% -2.1%
NIFTY SMALLCAP 250 -2.8% -10.2% -4.8%

You may also like the below Video Courses


FAQ about AKUMS DRUGS & PHARMACEUTICALS


Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?

As on Mar 13,2025, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Mar 13,2025, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?

As on Mar 13,2025, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 1.86 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -7.58
Fair Value [Median EV / Sales Model] : Rs. 1.86
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 1.86

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AKUMS DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Mar 13,2025, AKUMS DRUGS & PHARMACEUTICALS is trading at a Premium of 27350% based on the estimates of Median Intrinsic Value!